Search research articles
Contact Us
Filters
Showing results (321-330 of 382) with videos related to
Page
of 39
Sort By:
British Journal of Cancer
|
December 9, 2022
Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trial
Neil D Wallace, Mary T Dunne, Orla McArdle, et al.
Annals of Hematology
|
February 15, 2015
Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
Juan-Carlos Hernández-Boluda, Eduardo Arellano-Rodrigo, Francisco Cervantes, et al.
British Journal of Haematology
|
February 23, 2016
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera
Alberto Alvarez-Larrán, Ana Kerguelen, Juan C Hernández-Boluda, et al.
European Journal of Haematology
|
December 24, 2016
Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis
Juan-Carlos Hernández-Boluda, Juan-Gonzalo Correa, Regina García-Delgado, et al.
Intensive Care Medicine Experimental
|
February 7, 2025
Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label study
David Cosgrave, Bairbre McNicholas, Ciara Hanley, et al.
JAMA Network Open
|
December 9, 2022
Association of Psychosocial Stress With Risk of Acute Stroke
Catriona Reddin, Robert Murphy, Graeme J Hankey, et al.
Blood Cancer Journal
|
November 17, 2022
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
Tiziano Barbui, Arianna Ghirardi, Alessandra Carobbio, et al.
Acta Oncologica (Stockholm, Sweden)
|
June 5, 2025
TCHL - a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, trastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis
John Crown, Alex J Eustace, Denis M Collins, et al.
Annals of Hematology
|
July 2, 2014
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea
Alberto Alvarez-Larrán, Luz Martínez-Avilés, Juan Carlos Hernández-Boluda, et al.
Neurology
|
March 8, 2023
Depressive Symptoms and Risk of Acute Stroke: INTERSTROKE Case-Control Study
Robert P Murphy, Catriona Reddin, Annika Rosengren, et al.
Page
of 39
Search research articles
Search
Showing results (321-330 of 382) with videos related to
Sort By:
Page
of 39
British Journal of Cancer
|
December 9, 2022
Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trial
Neil D Wallace, Mary T Dunne, Orla McArdle, et al.
Annals of Hematology
|
February 15, 2015
Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
Juan-Carlos Hernández-Boluda, Eduardo Arellano-Rodrigo, Francisco Cervantes, et al.
British Journal of Haematology
|
February 23, 2016
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera
Alberto Alvarez-Larrán, Ana Kerguelen, Juan C Hernández-Boluda, et al.
European Journal of Haematology
|
December 24, 2016
Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis
Juan-Carlos Hernández-Boluda, Juan-Gonzalo Correa, Regina García-Delgado, et al.
Intensive Care Medicine Experimental
|
February 7, 2025
Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label study
David Cosgrave, Bairbre McNicholas, Ciara Hanley, et al.
JAMA Network Open
|
December 9, 2022
Association of Psychosocial Stress With Risk of Acute Stroke
Catriona Reddin, Robert Murphy, Graeme J Hankey, et al.
Blood Cancer Journal
|
November 17, 2022
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
Tiziano Barbui, Arianna Ghirardi, Alessandra Carobbio, et al.
Acta Oncologica (Stockholm, Sweden)
|
June 5, 2025
TCHL - a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, trastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis
John Crown, Alex J Eustace, Denis M Collins, et al.
Annals of Hematology
|
July 2, 2014
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea
Alberto Alvarez-Larrán, Luz Martínez-Avilés, Juan Carlos Hernández-Boluda, et al.
Neurology
|
March 8, 2023
Depressive Symptoms and Risk of Acute Stroke: INTERSTROKE Case-Control Study
Robert P Murphy, Catriona Reddin, Annika Rosengren, et al.
Page
of 39